INM · InMed Pharmaceuticals Inc. Common Shares
InMed Pharmaceuticals Inc (INM)
What's happening
- INM is up 2.64% today, trading at $1.36. — Live quote
- Volume today (736) is well below its 3-month average of 1,770,660. (Finnhub fundamentals)
- Reports earnings on 2026-09-21, 18 days away. (Finnhub earnings calendar)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Aggregate ratings for 2023-02-01 (8 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Mar '26 | Dec '25 | Sep '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|
| Market cap | $2.6M | $4.3M | $8.7M | $2.3M | $3.2M |
| P/E | -0.30 | -0.51 | -1.08 | -0.28 | -0.43 |
| Price/Sales | — | 1.00 | 1.83 | 0.47 | 0.67 |
| Price/Book | 0.38 | 0.45 | 0.75 | 0.32 | 0.52 |
| EV/Revenue | — | -0.62 | -0.13 | -0.50 | -0.04 |
| ROE | -128.30% | -88.15% | -69.89% | -115.31% | -120.57% |
| ROA | -96.81% | -75.51% | -60.63% | -87.25% | -87.67% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E and PEG aren't shown here — both need historical analyst-consensus estimates, which no free source provides; see the current-period figures above instead.
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-08-14. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Signals describe daily price patterns—not the company’s value and not a recommendation to buy or sell. Read several together; no single indicator predicts what happens next. “Overbought” and “oversold” are conditions, not promises of a reversal.
Indicators None active
Free IEX historical data only goes back to ~2021 — 5Y/Full show whatever's actually available, not a promise of that much history. Indicators are computed client-side from these same price bars; earnings markers ("E") come from Finnhub's free tier (~last 4 quarters + next upcoming) — older quarters aren't available. The move-highlight dots are a heuristic (|% change| vs rolling volatility) with a best-effort headline lookup, not a claim of causation.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 8-K, filed 2026-07-22; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -26.2% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -170.8%. Finnhub fundamentals ↗
- Trailing 52-week price return is -36.0%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on INM
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Mar '26 | Dec '25 | Sep '25 | Mar '25 | Dec '24 | Sep '24 | Mar '24 | Dec '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $820.2K | $1.1M | $1.3M | $1.1M | $1.3M | $1.2M | $1.2M |
| Gross profit | — | $184.2K | $403.2K | $175.6K | $460.9K | $493.4K | $289.5K | $324.1K |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | -$3.0M | -$2.0M | -$1.7M | -$2.1M | -$2.6M | -$1.7M | -$1.7M | -$1.5M |
| EPS (diluted) | $-0.73 | $-0.51 | $-0.44 | $-1.94 | $-3.64 | $-2.71 | $-3.58 | $-3.71 |
| EPS (basic) | $-0.73 | $-0.51 | $-0.44 | $-1.94 | $-3.64 | $-2.71 | $-3.58 | $-3.71 |
| Net margin | — | -$247 | -$154 | -$168 | -$232 | -$133 | -$147 | -$119 |
Balance sheet
| Line item | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $9.1M | $11.2M | $13.4M | $15.6M | $9.3M | $8.5M | $10.5M | $11.8M |
| Total liabilities | $2.2M | $1.6M | $1.8M | $2.1M | $2.3M | $2.3M | $2.1M | $2.6M |
| Stockholders' equity | $6.9M | $9.6M | $11.6M | $13.4M | $7.0M | $6.2M | $8.4M | $9.2M |
| Total current assets | $6.9M | $8.8M | $10.8M | $12.9M | $6.4M | $5.5M | $7.3M | $8.7M |
| Total current liabilities | $2.2M | $1.5M | $1.6M | $1.8M | $1.8M | $1.8M | $1.4M | $2.0M |
| Cash & equivalents | $5.2M | $7.0M | $9.3M | $10.7M | $4.7M | $3.4M | $5.6M | $6.6M |
| Marketable securities (current) | $41.6K | $42.7K | $42.9K | $43.4K | $40.6K | $40.8K | $43.2K | $43.1K |
| Accounts receivable | — | $183.0K | $343.5K | $465.1K | $367.8K | $262.6K | $284.7K | $352.8K |
| Inventory | — | $947.9K | $890.8K | $961.2K | $814.0K | $1.1M | $1.2M | $1.2M |
| Property, plant & equipment | $642.9K | $764.3K | $881.5K | $992.2K | $1.1M | $1.2M | $1.3M | $1.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible assets | $1.5M | $1.5M | $1.6M | $1.6M | $1.7M | $1.7M | $1.7M | $1.8M |
| Other non-current assets | $104.4K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K |
| Accounts payable | — | — | — | — | — | — | $2.0K | $41.0K |
| Accrued liabilities | — | — | — | — | — | — | $85.5K | $256.5K |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $92.6M | $92.0M | $91.8M | $91.2M | $87.5M | $84.5M | $84.2M | $82.8M |
| Retained earnings | -$124.0M | -$121.0M | -$119.0M | -$117.2M | -$115.4M | -$113.3M | -$110.8M | -$109.1M |
| Accumulated other comprehensive income (loss) | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K |
Cash flow
| Line item | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.7M | -$2.4M | -$1.6M | -$1.8M | -$1.7M | -$2.5M | -$1.8M | -$1.0M |
| Investing cash flow | — | — | — | — | — | — | — | $0 |
| Financing cash flow | $231.7K | $0 | -$137.2K | $8.2M | $2.9M | $338.5K | $838.2K | $176 |
| Free cash flow | — | — | — | — | — | — | — | -$1.0M |
| Capital expenditures | — | — | — | — | — | — | — | $0 |
| Depreciation & amortization | $50.5K | $53.2K | $53.2K | $52.8K | $52.3K | $53.2K | $54.6K | $54.8K |
| Share-based compensation | $38.8K | $25.3K | $20.2K | $26.7K | $40.5K | $23.2K | $29.0K | $39.0K |
| Change in accounts receivable | — | -$160.0K | -$122.2K | $99.7K | $105.2K | -$22.6K | -$67.6K | $145.2K |
| Change in inventory | — | $127.1K | -$70.4K | $147.2K | -$289.4K | -$116.7K | -$24.3K | $92.8K |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Other investing activities | — | — | — | — | — | — | — | — |
Income statement
| Line item | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 |
|---|---|---|---|---|---|
| Revenue | $4.9M | $4.6M | $4.1M | $1.1M | — |
| Gross profit | $1.7M | $1.1M | $1.4M | $543.5K | — |
| Operating income | — | — | -$7.9M | -$18.6M | -$10.2M |
| Net income | -$8.2M | -$7.7M | -$7.9M | -$18.6M | -$10.2M |
| EPS (diluted) | $-8.36 | $-20.14 | $-3.25 | $-33.17 | $-37.96 |
| EPS (basic) | $-8.36 | $-20.14 | $-3.25 | $-33.17 | $-37.96 |
| Operating margin | — | — | -$192 | -$1.7K | — |
| Net margin | -$165 | -$167 | -$192 | -$1.7K | — |
Balance sheet
| Line item | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 |
|---|---|---|---|---|---|
| Total assets | $15.6M | $11.8M | $14.1M | $12.8M | $9.8M |
| Total liabilities | $2.1M | $2.6M | $2.0M | $3.7M | $2.4M |
| Stockholders' equity | $13.4M | $9.2M | $12.1M | $9.1M | $7.4M |
| Total current assets | $12.9M | $8.7M | $11.3M | $9.6M | $8.4M |
| Total current liabilities | $1.8M | $2.0M | $2.0M | $3.3M | $2.2M |
| Cash & equivalents | $11.1M | $6.6M | $8.9M | $6.2M | $7.4M |
| Marketable securities (current) | $43.4K | $43.1K | $44.4K | $44.8K | $46.5K |
| Accounts receivable | $465.1K | $352.8K | $260.4K | $88.0K | $11.9K |
| Inventory | $961.2K | $1.2M | $1.6M | $2.5M | — |
| Property, plant & equipment | $992.2K | $1.2M | $723.4K | $904.3K | $326.6K |
| Intangible assets | $1.6M | $1.8M | $1.9M | $2.1M | $1.1M |
| Other non-current assets | $100.0K | $100.0K | $104.9K | $176.6K | $14.7K |
| Accounts payable | — | $41.0K | — | — | — |
| Accrued liabilities | — | $256.5K | $357.7K | — | — |
| Other current liabilities | — | — | — | $3.2M | $2.2M |
| Common stock & paid-in capital | $91.2M | $82.8M | $77.6M | $70.7M | $60.6M |
| Retained earnings | -$117.2M | -$109.1M | -$101.4M | -$93.5M | -$74.9M |
| Accumulated other comprehensive income (loss) | $128.6K | $128.6K | $128.6K | $128.6K | $128.6K |
Cash flow
| Line item | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$7.8M | -$7.0M | -$7.3M | -$15.6M | -$9.8M |
| Investing cash flow | — | -$9.3K | -$661.8K | -$673.0K | -$1.7K |
| Financing cash flow | $12.3M | $4.7M | $10.7M | $15.1M | $10.9M |
| Free cash flow | — | -$7.0M | -$7.4M | -$15.6M | -$9.8M |
| Capital expenditures | — | $9.3K | $160.0K | $39.1K | $1.7K |
| Depreciation & amortization | $212.8K | $219.6K | $202.2K | $185.7K | $120.9K |
| Share-based compensation | $119.3K | $137.7K | $278.2K | $697.9K | $610.2K |
| Change in accounts receivable | $114.7K | $92.4K | $219.1K | $40.0K | -$40.2K |
| Change in inventory | -$283.2K | -$66.2K | -$565.6K | $2.0M | — |
| Other investing activities | — | — | $1.8K | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding INM as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-05-19 to 2026-07-16
Recent transactions
- Insiders have net bought 745,875 shares over the last 182 days, across 34 purchases and 0 sales.
- Most recent: Vivo Opportunity, LLC (10% owner) — Open market purchase of 19 shares on 2026-07-16.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Vivo Opportunity, LLC | 10% owner | Open market purchase | 2026-07-16 | 19 |
| ADAR1 Capital Management, LLC | 10% owner | Open market purchase | 2026-07-15 | 1,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-16 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 19 | $1.55 |
| 2026-07-16 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 2 | $1.55 |
| 2026-07-15 | ADAR1 Capital Management, LLC | 10% owner | Open market purchase | 1,000 | $1.55 |
| 2026-07-15 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 13,761 | $1.55 |
| 2026-07-15 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 1,389 | $1.55 |
| 2026-07-14 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 4,882 | $1.55 |
| 2026-07-14 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 493 | $1.55 |
| 2026-07-02 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 1,460 | $1.55 |
| 2026-07-02 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 147 | $1.55 |
| 2026-07-01 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 3,946 | $1.55 |
| 2026-07-01 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 398 | $1.55 |
| 2026-06-30 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 545 | $1.54 |
| 2026-06-30 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 55 | $1.54 |
| 2026-06-08 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 29,518 | $1.52 |
| 2026-06-08 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 2,982 | $1.52 |
| 2026-06-05 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 49,966 | $1.57 |
| 2026-06-05 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 5,045 | $1.57 |
| 2026-06-04 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 6,125 | $1.57 |
| 2026-06-04 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 618 | $1.57 |
| 2026-06-03 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 7,069 | $1.55 |
| 2026-06-03 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 714 | $1.55 |
| 2026-06-02 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 20,753 | $1.52 |
| 2026-06-02 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 2,095 | $1.52 |
| 2026-06-01 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 14,838 | $1.55 |
| 2026-06-01 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 1,498 | $1.55 |
| 2026-05-29 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 16,164 | $1.57 |
| 2026-05-29 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 1,632 | $1.57 |
| 2026-05-21 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 30,882 | $1.69 |
| 2026-05-21 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 3,118 | $1.69 |
| 2026-05-20 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 51,056 | $1.56 |
| 2026-05-20 | Vivo Opportunity, LLC | 10% owner | Open market purchase | 5,154 | $1.56 |
| 2026-05-19 | ADAR1 Capital Management, LLC | 10% owner | Open market purchase | 68,551 | $1.60 |
| 2026-05-19 | ADAR1 Capital Management, LLC | 10% owner | Open market purchase | 200,000 | $1.56 |
| 2026-05-19 | ADAR1 Capital Management, LLC | 10% owner | Open market purchase | 200,000 | $1.50 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-09-03 12:04 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-07-22 | 8-K | 2026-07-22 | View on SEC.gov → |
| 2026-07-17 | 4 | 2026-07-15 | View on SEC.gov → |
| 2026-07-16 | 4 | 2026-07-14 | View on SEC.gov → |
| 2026-07-10 | 8-K | 2026-07-06 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-06-10 | 4 | 2026-05-20 | View on SEC.gov → |
| 2026-06-10 | 8-K | 2026-06-03 | View on SEC.gov → |
| 2026-05-21 | 4 | 2026-05-19 | View on SEC.gov → |
| 2026-05-19 | 8-K | 2026-05-19 | View on SEC.gov → |
| 2026-05-19 | 8-K | 2026-05-18 | View on SEC.gov → |
| 2026-05-07 | 8-K | 2026-05-06 | View on SEC.gov → |
| 2026-05-06 | 10-Q | 2026-03-31 | View on SEC.gov → |
Recent news
Headlines about INM (InMed Pharmaceuticals Inc. Common Shares). Links open the publisher — we don’t host full articles.
-
Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
Yahoo Finance · 2026-07-22 -
InMed Pharmaceuticals and Mentari Therapeutics Announce Amendment to Merger Agreement and Filing of Registration Statement on Form S-4
Yahoo Finance · 2026-07-06 -
InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements
Yahoo Finance · 2026-06-04 -
InMed Pharmaceuticals Inc. (INM) M&A Call Prepared Remarks Transcript
Seeking Alpha · 2026-05-25 -
INM Stock Alert: What to Know as InMed, Mentari Announce Merger
Yahoo Finance · 2026-05-20 -
/C O R R E C T I O N -- InMed Pharmaceuticals/
Yahoo Finance · 2026-05-20 -
InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM)
Yahoo Finance · 2026-05-19 -
InMed and Mentari announce all-stock merger deal
Seeking Alpha · 2026-05-19
No headlines in this category right now — try “All”.